View links to journals and guidelines used in the resource

Afessa, B. & Green, B. (2000). Bacterial pneumonia in hospitalised patients with HIV infection: the pulmonary complications, ICU support, and prognostic factors of hospitalised patients with HIV (PIP) study. Chest 117, Suppl. 4, 1017–22.

Akca, O., Koltka, K., Uzel, S., Cakar, N., Pembeci, K., Sayan, M. A. et al. (2000). Risk factors for early-onset, ventilator-associated pneumonia in critical care patients: selected multiresistant versus non-resistant bacteria. Anesthesiology 93, Suppl. 3, 638–45.

American Thoracic Society. Medical section of the American Lung Association (1995). Standards for the diagnosis and care of patients with Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine 152, 77–120.

Arakaki, N., Higa, F., Koide, M., Takeyama, M., Shinzato, T., Kusano, N. et al. (1999). Evaluation of urinary antigen detection methods for rapid diagnosis of Legionella pneumonia. Kansenshogaku Zasshi 73, Suppl. 5, 421–8.

Ball, P. (2000). Acute exacerbations of chronic bronchitis.  Current Opinion in Infectious Diseases 13, 171–6.

Ball, P. & Make, B.  (1998). Acute exacerbations of chronic bronchitis: an international comparison. Chest 113, Suppl. 3, 199–204.

Balter, M. S., Hyland, R. H., Low, D. E., Renzi, P. M., Brade, A. C., Cole, P. J. et al. (1994). Recommendations on the management of chronic bronchitis: A practical guide for Canadian physicians. Canadian Medical Association Journal 151, Suppl. 10, 5–23.

Bartlett, J. G. (1991). Antibiotics in lung abscess. Seminars in Respiratory Infections 6, Suppl. 2, 103–11.

Bartlett, J. G., Breiman, R. F., Mandell, L. A. & File, T. M. Jr.  (1998). Community-acquired pneumonia in adults: guidelines for management.  Guidelines from the Infectious Diseases Society of America.  Clinical Infectious Diseases 26, 811–38.

Bartlett, J. G., Dowell, S. F., Mandell, L. A., File, T. M. Jr., Musher, D. M. & Fine, M. J. (2000). Practice guidelines for the management of community-acquired pneumonia in adults.  Guidelines from the Infectious Diseases Society of America.  Clinical Infectious Diseases 31, 347–82.

Bauer, T. T. & Torres, A. (1999). Acute respiratory distress syndrome and nosocomial pneumonia. Thorax 54, Suppl. 11, 1036–40.

Beachey, E. H. & Simpson, W. A. (1982). The adherence of group A streptococci to oropharyngeal cells: the lipoteichoic acid adhesin and fibronectin receptor. Infection 10, Suppl. 2, 107–11.

Berger, A. (2000). Persistence of tuberculosis explained. British Medical Journal 321, 469.

Blasi, F., Cosentini, R. & Tarsia, P. (2000). Chlamydia pneumoniae respiratory infections.  Current Opinion in Infectious Diseases 13, 161–4.

Bodi, M., Ardanuy, C. & Rello, J. (2001).  Impact of Gram-positive resistance on outcome of nosocomial pneumonia. Critical Care Medicine 29, Suppl. 4, 82–6.

Boucher, B. A. (2000). Role of aztreonam in the treatment of nosocomial pneumonia in the critically ill surgical patient. American Journal of Surgery 179, Suppl, 2, 45–50.

Breiman, R. F. & Butler, J. C. (1998). Legionnaire’s disease: clinical, epidemiological, and public health perspectives. Seminars in Respiratory Infections 13, Suppl. 2, 84–9.

British Thoracic Society.  (1997). Guidelines on the Management of COPD.  The British Thoracic Society Standards of Care Committee.  Thorax 52, Suppl. 5, 1–28.

British Thoracic Society.  (2001). BTS Guidelines for the management of community acquired pneumonia in adults. Thorax 56, 1–64.

British Thoracic Society. (1993). Guidelines for the management of community-acquired pneumonia in adults admitted to hospital. British Journal of Hospital Medicine 49, Suppl. 5, 346–50.

British Thoracic Society. (1998). Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Thorax 53, 536–48.

Brown, E. M. (1997). Empirical antimicrobial therapy of mechanically ventilated patients with nosocomial pneumonia.  Journal of Antimicrobial Chemotherapy 40, 463–8.

Cassiere, H. A. (1998). Antibiotic therapy in community-acquired pneumonia: switch and step down therapy. Medscape Respiratory Care 2, Suppl. 3.

Chan, R., Hemeryck, L., O’Regan, M., Clancy, L. & Feely, J. (1995). Oral versus intravenous antibiotics for community acquired lower respiratory tract infection in a general hospital: open, randomised controlled trial. British Medical Journal 310, 1360–2.

Chastre, J. & Trouillet, J. L. (1995). Nosocomial pneumonia. Current Opinion in Pulmonary Medicine 1, 194–201.

Chastre, J., Trouillet, J. L., Vuagnat, A., Joly-Guillou, M. L., Clavier, H., Dombret, M. C. et al. (1998). Nosocomial pneumonia in patients with acute respiratory distress syndrome. American Journal of Respiratory and Critical Care Medicine 157, Suppl. 4, 1165–72.

Chenoweth, C. E., Saint, S., Martinez, F., Lynch, J. P. & Fendrick, A. M. (2000). Antimicrobial resistance in Streptococcus pneumoniae: implications for patients with community-acquired pneumonia. Mayo Clinic Proceedings 75, Suppl. 11, 1161–8.

Chevret, S., Hemmer, M., Carlet, J., Langer, M. & the European Cooperative Group on Nosocomial Pneumonia.  (1993). Incidence and risk factors of pneumonia acquired in intensive care units: results from a multicenter prospective study on 996 patients.  Intensive Care Medicine 19, Suppl. 5, 256–64.

Christie, P., Abraham, W., Lindsay, D. S. J., Johnston, F. & Girdwood, R. W. A. (1999). Legionella infections in Scotland: 1998.  Communicable Disease and Public Health 2, Suppl. 4, 285–6.

Clumeck, N. (1995). Primary prophylaxis against opportunistic infections in patients with AIDS.  New England Journal of Medicine 332, Suppl. 11, 739–40.

Cohen, R. A., Muzaffar, S., Schwartz, D., Bashir, S., Luke, S., McGartland, L. P. et al. (1998). Diagnosis of pulmonary tuberculosis using PCR assays on sputum collected within 24 hours of hospital admission.  American Journal of Respiratory and Critical Care Medicine 157, 156–61.

Coley, K. C., Skledar, S. J., Fine, M. J., Yealy, D. M., Gleason, P. P., Ryan, M. L. et al. (2000). Changing physician prescribing behavior: the community-acquired pneumonia intervention trial. American Journal of Health-System Pharmacy 57, Suppl. 15, 1506–10.

Community-acquired pneumonia in adults in British hospitals in 1982–1983: A survey of aetiology, mortality, prognostic factors and outcome. The British Thoracic Society and the Public Health Laboratory Service. Quarterly Journal of Medicine 62, Suppl. 239, 195–220.

Conant, E. F. & Wechsler, R. J. (1992). Actinomycosis and nocardiosis of the lung. Journal of Thoracic Imaging 7, Suppl. 4, 75–84.

Cook, D., De Jonghe, B., Brochard, L. & Brun-Buisson, C. (1998). Influence of airway management on ventilator-associated pneumonia: evidence from randomised trials. Journal of the American Medical Association 279, Suppl. 10, 781–7.

Costa, S. F., Newbaer, M., Santos, C. R., Basso, M., Soares, I. & Levin, A. S.  (2001).  Nosocomial pneumonia: importance of recognition of aetiological agents to define an appropriate initial empirical therapy. International Journal of Antimicrobial Agents 17, Suppl. 2, 147–50.

Crabtree, T. D., Gleason, T. G., Pruett, T. L. & Sawyer, R. G. (1999). Trends in nosocomial pneumonia in surgical patients as we approach the 21^st century: a prospective analysis. American Surgeon 65, Suppl. 8, 706–9.

Croce, M. A. (2000). Diagnosis of acute respiratory distress syndrome and differentiation from ventilator-associated pneumonia. American Journal of Surgery 179, Suppl. 1, 26–9.

Croce, M. A. (2000). Post Operative pneumonia.  The American Surgeon 66, 133–7.

Cunniffe, M. G., Maguire, D., McAnena, O. J., Johnston, S. & Gilmartin, J. J. (2000). Video-assisted thoracoscopic surgery in the management of loculated empyema. Surgical Endoscopy 14, Suppl. 2, 175–8.

Daffe, M. & Etienne, G. (1999). The capsule of Mycobacterium tuberculosis and its implications for pathogenicity. Tubercle and Lung Diseases 79, Suppl. 3, 153–69.

de Louvois, J. & Hurley, R. (1977). Inactivation of penicillin by purulent exudates. British Medical Journal 1, Suppl. 6067, 998–1000.

Delapenha, R. A., Cannon, D. L., Dawkins, F. W., Naab, T. J., Islam, S., Peters, B. D. et al. (1998). AIDS with disseminated histoplasmosis from a nonendemic area. Infections in Medicine 15, Suppl. 1, 45–9.

Department of Health and Human Services.  Food and Drug administration.  Premarket approval of Amplicor® Mycobacterium Tuberculosis Test.  www.fda.gov

Destache, C. J., Dewan, N., O’Donohue, W. J., Campbell, J. C. & Angelillo, V. A.  (1999). Clinical and economic considerations in the treatment of acute exacerbations of chronic bronchitis. Journal of Antimicrobial Chemotherapy 43, Suppl. A, 107–13.

Dowzicky, M., Talbot, G. H., Feger, C., Prokocimer, P., Etienne, J. & Leclercq, R. (2000). Characterization of isolates associated with emerging resistance to quinupristin/dalfopristin (Synercid^(R)) during a worldwide clinical program. Diagnostic Microbiology and Infectious Disease 37, Suppl. 1, 57–62.

Drakulovic, M. B., Torres, A., Bauer, T. T., Nicolas, J. M., Nogue, S. & Ferrer, M. (1999). Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial. Lancet 354, Suppl. 9193, 1851–8.

Drobinieski, F. A.  (1998).  Diagnosing multidrug resistant tuberculosis in Britain. Clinical suspicion should drive rapid diagnosis.  British Medical Journal 317, 1263–4.

Drobniewski, F. A., Watterson, S. A., Wilson, S. M. & Harris, G. S. (2000). A clinical, microbiological and economic analysis of a national service for the rapid molecular diagnosis of tuberculosis and rifampicin resistance in Mycobacterium tuberculosis. Journal of Medical Microbiology 49, Suppl. 3, 271–8.

Drobniewski, F. A. & Wilson, S. M. (1998). The rapid diagnosis of isoniazid and rifampicin in Mycobacterium tuberculosis — a molecular story. Journal of Medical Microbiology 47, Suppl. 3, 189–96.

Fagon, J. Y., Chastre, J., Wolff, M., Gervais, C., Parer-Aubas, S., Stephan, F. et al. (2000). Invasive and non-invasive strategies for management of suspected ventilator-associated pneumonia. A randomised trial. Annals of Internal Medicine 132, Suppl. 8, 621–30.

Fagon, J., Patrick, H., Haas, D. W., Torres, A., Gibert, C., Cheadle, W. G. et al. (2000). Treatment of Gram-positive nosocomial pneumonia. Prospective randomised comparison of quinupristin/dalfopristin versus vancomycin. Nosocomial Pneumonia Group. American Journal of Respiratory and Critical Care Medicine 161, Suppl. 3, 753–62.

Farber, M. O. (1999).  Managing community-acquired pneumonia  Factors to consider in outpatient care. Postgraduate Medicine 105, Suppl. 4, 106–14.

Farr, B. M. (1997). Prognosis and decisions in pneumonia.  New England Journal of Medicine 336, Suppl. 4, 288–9.

Feldman, C., Kassel, M., Cantrell, J., Kaka, S., Morar, R., Goolam Mahomed, A. et al. (1999). The presence and sequence of endotracheal tube colonization in patients undergoing mechanical ventilation. European Respiratory Journal 13, Suppl. 3, 546–51.

Felmingham, D., Robbins, M. J., Tesfaslasie, Y., Harding, I., Shrimpton, S. & Gruneberg, R. N. (1998). Antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens isolated in the UK during the 1995–1996 cold season. Journal of Antimicrobial Chemotherapy 41, Suppl. 3, 411–5.

File, T. M. (2000). New millennium: new antimicrobial agents for respiratory infections; but an old plea. Current Opinion in Infectious Diseases 13, 141–3.

Finch, R. G.  (1995).  Pneumonia: the impact of antibiotic resistance on its management. Microbial Drug Resistance 1, Suppl. 2, 149–58.

Fine, M. J., Auble, R. E., Yealy, D. M., Hanusa, B. H., Weissfeld, L. A., Singer, D. E. et al. (1997). A predication rule to identify low-risk patients with community-acquired pneumonia. New England Journal of Medicine 336, Suppl. 4, 243–50.

Flanagan, P. G.  (1999). Diagnosis of ventilator-associated pneumonia. Journal of Hospital Infection 41, 87–99.

Gales, M. & Phillips, C. M. (1997).  Coccidiomycosis — a mycotic infection on the rise.  Clinician Reviews 7, Suppl. 40, 71–84.

Garcia, M. S., Cambronero Galache, J. A., Lopez Diaz, J., Cerda, E. D., Blasco, J. R., Gomez, M A. et al. (1998). Effectiveness and cost of selective decontamination of the digestive tract in critically ill intubated patients.  A randomised, double-blind, placebo-controlled multicenter trial. American Journal of Respiratory and Critical Care Medicine 158, 908–16.

Garcia-Ordonez, M. A., Garcia-Jimenez, J. M., Paez, F., Alvarez, F., Poyato, B., Franquelo, M. et al. (2001). Clinical aspects and prognostic factors in elderly patients hospitalised for community-acquired pneumonia. European Journal of Clinical Microbiology and Infectious Diseases 20, Suppl. 1, 14–9.

Garibaldi, R. A.  (1985). Epidemiology of community-acquired respiratory tract infections in adults.  Incidence, etiology and impact.  The American Journal of Medicine 78, Suppl. 6B, 32–7.

Gbayisomore, A., Lardizabeal, A. A. & Reichman, L. B. (2000). Update: prevention and treatment of tuberculosis. Current Opinion in Infectious Diseases 13, 155–9.

Gelband, H. (2000).  Regimens of less than six months for treating tuberculosis (Cochrane Review). In: The Cochrane Library, 3.

Georges, H., Leroy, O., Alfandari, S., Guery, B., Roussel-Delvallez, M., Dhennain, C. et al.  (1997). Pulmonary disposition of vancomycin in critically ill patients. European Journal of Clinical Microbiology and Infectious Diseases 16, Suppl. 5, 385–8.

Gin, A. S. (2000).  Community-acquired pneumonia — What is the state of the art? Journal of Informed Pharmacotherapy 3, 336–44.

Gómez, J., Esquinas, A., Agudo, M. D., Sánchez Nieto, J. M., Núnez, M. L., Banos, V. et al.  (1995). Retrospective analysis of risk factors and prognosis in non-ventilated patients with nosocomial pneumonia.  European Journal of Clinical Microbiology and Infectious Diseases 14, 176–81.

Goossens, H. & Sprenger, M. J. W. (1998). Community acquired infections and bacterial resistance. British Medical Journal 317, 654–7.

Grossman, R. F. (1997). The role of fluroroquinolones in respiratory tract infection. Journal of Antimicrobial Chemotherapy 40, Suppl. A, 59–62.

Grossman, R. F. (2000). Cost-effective therapy for acute exacerbations of chronic bronchitis.   Seminars in Respiratory Infection 15, Suppl. 1, 71–81.

Gruson, D., Hilbert, G., Vargas, F., Valentino, R., Bebear, C., Allery, A. et al. (2000). Rotation and restricted use of antibiotics in a medical intensive care unit. Impact on the incidence of ventilator-associated pneumonia caused by antibiotic-resistant Gram-negative bacteria. American Journal of Respiratory and Critical Care Medicine 162, Suppl. 3, 837–43.

Guest, J. F. & Morris, A. (1997). Community-acquired pneumonia: the annual cost to the National Health Service in the UK.  European Respiratory Journal 10, Suppl. 7, 1530–4.

Heath, C. H., Grove, D. I. & Looke, D. F. (1996). Delay in appropriate therapy of Legionella pneumonia associated with increased mortality. European Journal of Clinical Microbiology and Infectious Diseases 15, Suppl. 4, 286–90.

Heffelfinger, J. D., Dowell, S. F., Jorgensen, J. H., Klugman, K. P., Mabry, L. R., Musher, D. M. et al. (2000). Management of community-acquired pneumonia in the era of pneumococcal resistance. Archives of Internal Medicine 160, 1399–408.

Hernandez Borge, J., Alfageme Michavila, I., Munoz Mendez, J., Campos Rodriguez, F., Pena Grinan, N. & Villagomez Cerrato, R. (1998). Thoracic empyema in HIV-infected patients: microbiology, management and outcome. Chest 113, Suppl. 3, 732–8.

Hirani, N. A. & Macfarlane, J. T. (1997). Impact of management guidelines on the outcome of severe community acquired pneumonia. Thorax 52, 17–21.

Hirshberg, B., Sklair-Levi, M., Nir-Paz, R., Ben-Sira, L., Krivoruk, V. & Kramer, M. R. (1999).  Factors predicting mortality of patients with lung abscess. Chest 115, Suppl. 3, 746–50.

Horsburgh, C. R., Feldman, S. & Ridzon, R. (2000). Practice guidelines for the treatment of tuberculosis. Guidelines from the Infectious Diseases Society of America.  Clinical Infectious Diseases 31, 633–9.

Hosker, H. S. R., Jones, G. M. & Hawkey, P. (1994). Fortnightly review: management of community acquired lower respiratory tract infection. British Medical Journal 308, 701–5.

Inglis, T. J. J., Garrow, S. C., Henderson, M., Clair, A., Sampson, J., O'Reilly, L. et al. (2000).  Burkholderia pseudomallei traced to water treatment plant in Australia.  Emerging Infectious Diseases 6, Suppl. 1, 56–9.

Johnson, S. R. & Pavord, I. D. (1996). Grand Rounds — City Hospital, Nottingham: A complicated case of community acquired pneumonia. British Medical Journal 312, 899–901.

Joint Tuberculosis Committee of the British Thoracic Society. (1998). Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Thorax 53, 536–48.

Joint Tuberculosis Committee of the British Thoracic Society. (2002). Control and prevention of tuberculosis in the United Kingdom: code of practice 2000. Thorax 55, 887–901.

Jones, G. R. (1995). A re-evaluation of blood cultures.  Reviews in Medical Microbiology 6, Suppl. 2, 109–18.

Joseph, C. A., Harrison, T. G., Ilijic-Car, D. & Bartlett, C. L. R. (1999). Legionnaires’ disease in residents of England and Wales: 1998. Communicable Disease and Public Health 2, 280–4.

Koerner, R. J. (1997). Contribution of endotracheal tubes to the pathogenesis of ventilator-associated pneumonia. Journal of Hospital Infection 35, 83–9.

Kohler, R. B. (1999). Severe pneumonia. When and why to hospitalise. Postgraduate Medicine 105, Suppl. 4, 117–24.

Kollef, M. H.  (1999). The prevention of ventilator-associated pneumonia.  New England Journal of Medicine 340, Suppl. 8, 627–33.

Kollef, M. H. (2000). Opinion: the clinical use of selective digestive decontamination. Critical Care 4, Suppl. 6, 327–32.

Koontz, C. S., Chang, M. C. & Meredith, J. W. (2000).  Effects of empiric antibiotic administration for suspected pneumonia on subsequent opportunistic pulmonary infections.  The American Surgeon 66, 1110–5.

Lê, C. T. & Crane, T.  (1997). Rhodococcus equi in an AIDS patient. The AIDS Reader 7, Suppl. 2, 70–2.

Leal-Noval, S. R., Marquez-Vacaro, J. A., Garcia-Curiel, A., Camacho-Larana, P., Rincon-Ferrari, M. D., Ordonez-Fernandez, A. et al. (2000). Nosocomial pneumonia in patients undergoing heart surgery. Critical Care Medicine 28, Suppl. 4, 935–40.

Liberati, A., D’Amico, R., Pifferi, S., Leonetti, C., Torri, V., Brazzi, L. et al.  (2000). Antibiotics for preventing respiratory tract infections in adults receiving intensive care.  The Cochrane Library 2.

Lim, W. S., Lewis, S. & Macfarlane, J. T. (2000). Severity prediction rules in community acquired pneumonia: a validation study. Thorax 55, Suppl. 3, 219–23.

Lim, W. S., Macfarlane, J. T., Boswell, T. C. J., Harrison, T.G., Rose, D., Leinonen, M. et al. (2001). Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines.  Thorax 56, 296–301.

Linder, R. (1997). Rhodococcus equi and Arcanobacterium haemolyticum: two “Coryneform” bacteria increasingly recognized as agents of human infection. Emerging Infectious Diseases 3, Suppl. 2, 145–53.

Lode, H., Raffenberg, M., Erbes, R., Geerdes-Fenge, H. & Mauch, H.  (2000). Nosocomial pneumonia: epidemiology, pathogenesis, diagnosis, treatment and prevention. Current Opinion in Infectious Diseases 13, 377–84.

Low, D. E. (2000). Trends and significance of antimicrobial resistance in respiratory pathogens. Current Opinion in Infectious Diseases 13, 145–53.

MacFarlane, J. (1987). Community-acquired pneumonia.  British Journal of Diseases of the Chest 81, 116–27.

Mandell, L. A. & Campbell, G. D. Jr. (1998). Nosocomial Pneumonia Guidelines.  An International Perspective.  Chest 113, 188–93.

Markowicz, P., Wolff, M., Djedaini, K., Cohen, Y., Chastre, J., Delclaux, C. et al. (2000). Multicenter prospective study of ventilator-associated pneumonia during acute respiratory distress syndrome. Incidence, prognosis, and risk factors. ARDS Study Group. American Journal of Respiratory and Critical Care Medicine 161, Suppl. 6, 1942–8.

Marsh, B., Hone, R., White, M., Phelan, D., Fabry, J. & the Irish Intensive Care Nosocomial Pneumonia Survey Group. (1996). European nosocomial infection survey:  analysis of Irish data.  Irish Medical Journal 89, Suppl. 3, 96–8.

Mason, C. M., Bawdon, R. E., Pierce, A. K. & Dal Nogare, A. R.  (1990).  Fibronectin is not detectable on the intact buccal epithelial surface of normal rats or humans. American Journal of Respiratory Cell and Molecular Biology 3, Suppl. 6, 563–70.

Meehan, T. P., Fine, M. J., Krumholz, H. M., Scinto, J. D., Galusha, D. H., Mockalis, J. T. et al. (1997). Quality of care, process, and outcomes in elderly patients with pneumonia. Journal of the American Medical Association 278, Suppl. 23, 2080–4.

Messori, A., Trippoli, S., Vaiani, M., Gorini, M. & Corrado, A. (2000). Bleeding and pneumonia in intensive care patients given ranitidine and sucralfate for prevention of stress ulcer: meta-analysis of randomised controlled trials. British Medical Journal 321, 1103–6.

Neill, A. M., Martin, I. R., Weir, R., Anderson, R., Chereshsky, A., Epton, M. J. et al.  (1996). Community acquired pneumonia: aetiology and usefulness of severity criteria on admission. Thorax 51, 1010–6.

Nicolson, P. & Anderson, P.  (2000). The patient's burden: physical and psychological effects of acute exacerbations of chronic bronchitis. Journal of Antimicrobial Chemotherapy 45, 25–32.

Niederman, M. S., Bass, J. B., Campbell, G. D., Fein, A. M., Grossman, R. F., Mandell, L. A. et al. (1993). Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity; and initial antimicrobial therapy. American Review of Respiratory Diseases 148, 1418–26.

Nourdine, K., Combes, P., Carton, M. J., Beuret, P., Cannamela, A. & Ducreux, J. C. (1999). Does non-invasive ventilation reduce the ICU nosocomial infection risk? A prospective clinical survey. Intensive Care Medicine 25, Suppl. 6, 567–73.

Obaro, S. K., Monteil, M. A. & Henderson, D. C. (1996). Fortnightly review: The pneumococcal problem. British Medical Journal 312, 1521–5.

Patterson, W. J., Hay, J., Seal, D. V. & McLuckie, J. C.  (1997). Colonization of transplant unit water supplies with Legionella and protozoa: precautions required to reduce the risk of legionellosis. Journal of Hospital Infection 37, Suppl. 1, 7–17.

Peeling, R. W. & Brunham, R. C. (1996). Chlamydiae as pathogens: new species and new issues. Emerging Infectious Diseases 2, Suppl. 4, 307–19.

Read, R. C. & Pennington, J. E. (1998). Respiratory Tract Infection. Health Press Ltd, Oxford.

Read, R. C.  (1999).  Infection in acute exacerbations of chronic bronchitis: a clinical perspective. Respiratory Medicine 93, Suppl. 12, 845–50.

Roche, N. (1999). Recent advances.  Pulmonary medicine. British Medical Journal 318, 171–6.

Rubinstein, E., Cammarata, S., Oliphant, T. & Wunderink, R.  (2001).  Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study. Clinical Infectious Diseases 32, Suppl. 3, 402–12.

Samuel, M. & Ti, T. Y. (2001). Interventions for treating melioidosis. The Cochrane Library 2.

Sanguinetti, M., Posteraro, B., Ardito, F., Zanetti, S., Cingolani, A., Sechi, L. et al. (1998).  Routine Use of PCR–reverse cross-blot hybridization assay for rapid identification of Mycobacterium species growing in liquid media. Journal of Clinical Microbiology  36, Suppl. 6, 1530–3.

Sarosi, G. A. (1999).  'Atypical pneumonia.'  Why this term may be better left unsaid. Postgraduate Medicine 105, Suppl. 4, 131–8.

Schentag, J. J. (1999). Antimicrobial action and pharmacokinetics/pharmacodynamics: the use of AUIC to improve efficacy and avoid resistance. Journal of Chemotherapy 11, Suppl. 6, 426–39.

Scott, S. M., Sethi, G. K., Takaro, T. & Enright, T. J.  (1987). Thoracic surgical infections. In: Surgical Infectious Diseases. (Howard, R. J. & Simmons, R. L. Eds) Appleton and Lange.

Sethi, S. (2000). Infectious etiology of acute exacerbations of chronic bronchitis. Chest 117, Suppl. 2, 380–5.

Skerrett, S. J.  (1999). Diagnostic testing for community-acquired pneumonia. Clinics in Chest Medicine 20, Suppl. 3, 531–48.

Smieja, M. J., Marchetti, C. A., Cook, D. J. & Smaill, F. M.  (2001). Isoniazid for preventing tuberculosis in non-HIV infected persons (Cochrane Review). In: The Cochrane Library 1.

Stoutenbeek, C. P. & van Saene, H. K.  (1997). Nonantibiotic measures in the prevention of ventilator-associated pneumonia. Seminars in Respiratory Infections 12, Suppl. 4, 294–9.

Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society. (2000). Management of opportunist mycobacterial infections: Joint Tuberculosis Committee Guidelines 1999. Thorax 55, 210–18.

Tan, M. J., Tan, J. S., Hamor, R. H., File, T. M. Jr. & Breiman, R. F. (2000). The radiologic manifestations of Legionnaire’s disease. The Ohio community-based pneumonia incidence study group. Chest 117, Suppl. 2, 398–403.

The Interdepartmental Working Group on Tuberculosis. (1998). Control and Prevention of Tuberculosis in the United Kingdom.  UK Guidance on the prevention and control of transmission of 1. HIV-related tuberculosis. 2.  Drug-resistant, including multiple drug-resistant, tuberculosis.  Department of Health Report.  www.doh.gov.uk

Thomsen, V. Ø., Kok-Jensen, A., Buser, M., Philippi-Schulz, S. & Burkardt, H-J. (1999). Monitoring Treatment of Patients with Pulmonary Tuberculosis: Can PCR Be Applied? Journal of Clinical Microbiology 37, Suppl. 11, 3601–7.

Thornsberry, C. & Sahm, D. F.  (2000). Resistance in respiratory tract pathogens: an international study 1997–1998. Journal of Chemotherapy 12, Suppl. 4, 16–20.

Tomasz, A. (1995). The Pneumococcus at the gates. New England Journal of Medicine 333, 514–5.

Torres, A., El-Ebiary, M., Soler, N., Monton, C., Fabregas, N. & Hernandez, C. (1996). Stomach as a source of colonization of the respiratory tract during mechanical ventilation: association with ventilator-associated pneumonia. European Respiratory Journal 9, Suppl. 8, 1729–35.

Unertl, K. E., Lenhart, F. P., Forst, H. & Peter, K. (1992). Systemic antibiotic treatment of nosocomial pneumonia. Intensive Care Medicine 18, Suppl 1, 28–34.

Volmink, J. & Garner, P. (2000). Interventions for promoting adherence to tuberculosis management. The Cochrane Library 3.

Wallace, W. C., Cinat, M., Gornick, W. B., Lekawa, M. E. & Wilson, S. E. (1999). Nosocomial infections in the surgical intensive care unit: a difference between trauma and surgical patients. American Surgeon 65, Suppl. 10, 987–90.

Waterer, G. W., Baselski, V. S. & Wunderink, R. G.  (2001). Legionella and community-acquired pneumonia: a review of current diagnostic tests from a clinician's viewpoint. American Journal of Medicine 110, Suppl. 1, 41–8.

Waterer, G. W., Jennings, S. G. & Wunderink, R. G.  (1999). The impact of blood cultures on antibiotic therapy in pneumococcal pneumonia. Chest 116, Suppl. 5, 1278–81.

Waterer, G. W. & Wunderink, R. G.  (2001). The influence of the severity of community-acquired pneumonia on the usefulness of blood cultures. Respiratory Medicine 95, Suppl. 1, 78–82.

Wheat, J. (1995). Endemic Mycoses in AIDS: a Clinical Review. Clinical Microbiology Reviews 8, 1146–59.

Wilkinson, D. (2000). Drugs for preventing tuberculosis in HIV infected persons (Cochrane Review). In: The Cochrane Library 3.

Wilson, R. & Grossman, R.  (2000). Introduction: the role of bacterial infection in chronic bronchitis. Seminars in Respiratory Infection 15, Suppl. 1, 1–6.

Wise, R. (1999). A review of the clinical pharmacology of moxifloxacin, a new 8-methoxyquinolone, and its potential relation to therapeutic efficacy. Clinical Drug Investigation 17, Suppl. 5, 365–87.

Wise, R. (2000). Clinical efficacy and antimicrobial pharmacodynamics. Hospital Medicine 61, Suppl. 1, 24–30.

Woodhead, M. & Torres, A. (1997). Definition and classification of community-acquired and nosocomial pneumonias. European Respiratory Monograph  3, 1–12.

Woods, D. E.  (1987). Role of fibronectin in the pathogenesis of Gram-negative bacillary pneumonia. Reviews in Infectious Diseases 9, Suppl. 4, 386–90.

Wort, S. J. & Rogers, T. R. (1998). Community acquired pneumonia in elderly people. British Medical Journal 316, 1690.

Zervos, M. J., Skupien, D. & Dmuchowski, C. F. (1997). Metaanalysis of the efficacy and safety of ampicillin/sulbactam in the treatment of patients with bacterial infections of the lower respiratory tract. Infectious Diseases in Clinical Practice 6, Suppl. 7, 473–81.